In March, Rick Bright requested the FDA issue an "Emergency Use Authorization (EUA) for emergency use of oral formulations of chloroquine phosphate and hydroxychloroquine sulfate for the treatment of 2019 coronavirus disease (COVID-19)..."
https://www.fda.gov/media/136534/download

This "emergency" request to allow doctors to prescribe chloroquine is not mentioned in this @maggieNYT- @shearm @nytimes piece about Bright's ouster, though Bright seems to allude to it here:
https://www.nytimes.com/2020/04/22/us/politics/rick-bright-trump-hydroxychloroquine.html

He says "he insisted"... I do not have the text of his request, but the FDA's response puts the limitations he mentioned today as a condition for the approval back in March.
https://www.fda.gov/media/136534/download

At the same time the FDA granted Bright's request, "HHS accepted [30 million doses of hydroxychloroquine sulfate] to Strategic National Stockpile as possible treatments for COVID-19 patients"
https://www.hhs.gov/about/news/2020/03/29/hhs-accepts-donations-of-medicine-to-strategic-national-stockpile-as-possible-treatments-for-covid-19-patients.html

BARDA noted the donation on its website:
https://www.phe.gov/about/barda/Pages/default.aspx

I am not jumping to conclusions - there's not enough known. It would help if the @FDA could release the text of Bright's request for the emergency authorization so his outlook on the potential of the drugs was more clear.